Ligand efficiency indices are widely used to guide chemical optimization in drug discovery, due to their predictive value in the early steps of optimization. At later stages however, as more complex properties become critical for success, indices relying on calculated, rather than experimental parameters become less informative. This problem is particularly acute when developing positron emission tomography (PET) imaging agents, for which non-specific binding to membranes (NSB) is a frequent cause of failure. NSB cannot be predicted using in silico parameters. To address this gap, we explored the use of the experimentally determined chromatographic hydrophobicity index on immobilized artificial membranes, CHI(IAM), to guide the optimization...
Positron emission tomography (PET) is increasingly being used by the pharmaceutical industry in drug...
The triage of compounds at the single-concentration screening phase of high-throughput screening (HT...
Abstract Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can ...
Abstract: Non-specific binding (NSB) is a key parameter in optimizing PET imaging tracers. We compar...
Nonspecific binding is a poorly understood biological phenomenon of relevance in the study of small ...
The discovery of novel imaging agents for positron emission tomography (PET) relies on medicinal che...
Positron emission tomography (PET) is a valuable non-invasive technique for the visualization of dru...
Background: Development of tracers for imaging with positron emission tomography (PET) is often a ti...
To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission t...
High non-specific binding (NSB) is one of the most common reasons for candidate failure in potential...
The non-invasive imaging modality positron emission tomography (PET) is used extensively in clinical...
The drug discovery process can be accelerated by chromatographic profiling of the analogs to model i...
This study investigated positron emission tomography (PET) agents, which can be bind to Glutamate Tr...
PET enables us to quantify various functionalities of living tissue such as receptor density and the...
The non-invasive imaging modality positron emission tomography (PET) is used extensively in clinical...
Positron emission tomography (PET) is increasingly being used by the pharmaceutical industry in drug...
The triage of compounds at the single-concentration screening phase of high-throughput screening (HT...
Abstract Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can ...
Abstract: Non-specific binding (NSB) is a key parameter in optimizing PET imaging tracers. We compar...
Nonspecific binding is a poorly understood biological phenomenon of relevance in the study of small ...
The discovery of novel imaging agents for positron emission tomography (PET) relies on medicinal che...
Positron emission tomography (PET) is a valuable non-invasive technique for the visualization of dru...
Background: Development of tracers for imaging with positron emission tomography (PET) is often a ti...
To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission t...
High non-specific binding (NSB) is one of the most common reasons for candidate failure in potential...
The non-invasive imaging modality positron emission tomography (PET) is used extensively in clinical...
The drug discovery process can be accelerated by chromatographic profiling of the analogs to model i...
This study investigated positron emission tomography (PET) agents, which can be bind to Glutamate Tr...
PET enables us to quantify various functionalities of living tissue such as receptor density and the...
The non-invasive imaging modality positron emission tomography (PET) is used extensively in clinical...
Positron emission tomography (PET) is increasingly being used by the pharmaceutical industry in drug...
The triage of compounds at the single-concentration screening phase of high-throughput screening (HT...
Abstract Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can ...